litlas
Log inCreate account

Yves Pommier

Active 1982–2025

Also published as
Yves Pommier
397
Papers
64,878
Citations
140
h-index
383
i10-index

Citations

Citations per year for Yves Pommier1971: 1 citations1982: 1 citations1983: 1 citations1984: 6 citations1985: 13 citations1986: 8 citations1987: 32 citations1988: 17 citations1989: 38 citations1990: 36 citations1991: 53 citations1992: 43 citations1993: 66 citations1994: 107 citations1995: 113 citations1996: 134 citations1997: 231 citations1998: 269 citations1999: 302 citations2000: 281 citations2001: 346 citations2002: 352 citations2003: 410 citations2004: 404 citations2005: 421 citations2006: 466 citations2007: 439 citations2008: 414 citations2009: 467 citations2010: 482 citations2011: 493 citations2012: 545 citations2013: 531 citations2014: 586 citations2015: 504 citations2016: 500 citations2017: 523 citations2018: 483 citations2019: 1,764 citations2020: 1,962 citations2021: 2,112 citations2022: 1,811 citations2023: 1,250 citations2024: 2,133 citations2025: 875 citations2026: 34 citations1972–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,946 citing papers, 30% of this breakdownChina: 2,214 citing papers, 11.2% of this breakdownUnited Kingdom: 1,386 citing papers, 7% of this breakdownGermany: 849 citing papers, 4.3% of this breakdownItaly: 825 citing papers, 4.2% of this breakdownFrance: 821 citing papers, 4.1% of this breakdownJapan: 682 citing papers, 3.4% of this breakdownIndia: 619 citing papers, 3.1% of this breakdownCanada: 603 citing papers, 3% of this breakdownSpain: 524 citing papers, 2.7% of this breakdownAustralia: 378 citing papers, 1.9% of this breakdownNetherlands: 352 citing papers, 1.8% of this breakdown
0%30%Other 23.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology52.8%
  • Medicine33.6%
  • Immunology and Microbiology3%
  • Computer Science2.6%
  • Chemistry2.4%
  • Materials Science1.3%
  • Other4.3%

Topics

  • DNA Repair Mechanisms7.8%
  • Cancer therapeutics and mechanisms5.2%
  • PARP inhibition in cancer therapy4.5%
  • Cancer-related Molecular Pathways2%
  • Genomics and Chromatin Dynamics1.9%
  • CRISPR and Genetic Engineering1.8%
  • Other76.8%

Coauthors

All papers

Open in search
  1. Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

    Authors: Junko Murai, Shar-yin N. Huang, Benu Brata Das, Amèlie Renaud, Yiping Zhang, James H. Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier - Cancer Research 2012 cited by 2,179

  2. Topoisomerase I inhibitors: camptothecins and beyond

    Authors: Yves Pommier - Nature reviews. Cancer 2006 cited by 2,226

  3. Human topoisomerases and their roles in genome stability and organization

    Authors: Yves Pommier, André Nussenzweig, Shunichi Takeda, Caroline A. Austin - Nature Reviews Molecular Cell Biology 2022 cited by 456

  4. CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set

    Authors: William C. Reinhold, Margot Sunshine, Hongfang Liu, Sudhir Varma, Kurt W. Kohn, Joel Morris, James H. Doroshow, Yves Pommier - Cancer Research 2012 cited by 931

  5. Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action

    Authors: Yves Pommier, Mark J. O’Connor, Johann S. de Bono - Science Translational Medicine 2016 cited by 759

  6. MGMT Status as a Clinical Biomarker in Glioblastoma

    Authors: Madison Butler, Lőrinc Sándor Pongor, Yuting Su, Liqiang Xi, Mark Raffeld, Martha Quezado, Jane B. Trepel, Kenneth Aldape, Yves Pommier, Jing Wu - Trends in cancer 2020 cited by 346

  7. DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs

    Authors: Yves Pommier, Elisabetta Leo, Hongliang Zhang, Christophe Marchand - Chemistry & Biology 2010 cited by 1,827

  8. Roles of eukaryotic topoisomerases in transcription, replication and genomic stability

    Authors: Yves Pommier, Yilun Sun, Shar-yin N. Huang, John L. Nitiss - Nature Reviews Molecular Cell Biology 2016 cited by 960

  9. γH2AX and cancer

    Authors: William M. Bonner, Christophe E. Redon, Jennifer S. Dickey, Asako Nakamura, Olga A. Sedelnikova, Stéphanie Solier, Yves Pommier - Nature reviews. Cancer 2008 cited by 1,606

  10. Genomic and evolutionary classification of lung cancer in never smokers

    Authors: Tongwu Zhang, Philippe Joubert, Naser Ansari‐Pour, Zhao Wei, Phuc H. Hoang, Rachel Lokanga, Aaron L. Moye, Jennifer Rosenbaum, Abel González-Pérez, Francisco Martínez-Jiménez, Andrea Castro, Lucia Anna Muscarella, Paul L. Hofman, Dario Consonni, Angela Cecilia Pesatori, Michael Kebede, Mengying Li, Bonnie E. Gould Rothberg, Iliana Peneva, Matthew B. Schabath, Maria Luana Poeta, Manuela Costantini, Daniela Hirsch, Kerstin Heselmeyer‐Haddad, Amy Hutchinson, Mary E. Olanich, Scott M. Lawrence, Petra H. Lenz, Máire A. Duggan, Praphulla Bhawsar, Jian Sang, Jung Kim, Laura Mendoza, Natalie Saini, Leszek J. Klimczak, S. M. Ashiqul Islam, Burçak Otlu, Azhar Khandekar, Nathan Cole, Douglas R. Stewart, Jiyeon Choi, Kevin M. Brown, Neil E. Caporaso, Samuel H. Wilson, Yves Pommier, Qing Lan, Nathaniel Rothman, Jonas S. Almeida, Hannah Carter, Thomas Ried, Carla F. Kim, Núria López-Bigas, Montserrat García‐Closas, Jianxin Shi, Yohan Bossé, Bin Zhu, Dmitry A. Gordenin, Ludmil B. Alexandrov, Stephen J. Chanock, David C. Wedge, Maria Teresa Landi - Nature Genetics 2021 cited by 242

  11. A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress

    Authors: Peter M. Bruno, Yunpeng Liu, Ga Young Park, Junko Murai, Catherine Koch, Timothy J. Eisen, Justin R. Pritchard, Yves Pommier, Stephen J. Lippard, Michael T. Hemann - Nature Medicine 2017 cited by 525

  12. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes

    Authors: Lőrinc Sándor Pongor, Christopher W. Schultz, Lorenzo Rinaldi, Darawalee Wangsa, Christophe E. Redon, Nobuyuki Takahashi, Gavriel Fialkoff, Parth Desai, Yang Zhang, Sandra Burkett, Nadav Hermoni, Noa Vilk, Jenia Gutin, Rona Gergely, Yongmei Zhao, Samantha Nichols, Rasa Vilimas, Linda Sciuto, Chante Graham, Juan Manuel Caravaca, Sevilay Turan, Tsai-Wei Shen, Vinodh N. Rajapakse, Rajesh Kumar, Deep Upadhyay, Suresh Kumar, Yoo Sun Kim, Nitin Roper, Bao Tran, Stephen M. Hewitt, David E. Kleiner, Mirit I. Aladjem, Nir Friedman, Gordon L. Hager, Yves Pommier, Thomas Ried, Anish Thomas - Cancer Discovery 2023 cited by 116

  13. Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers

    Authors: Song Qu, Patricia Fetsch, Anish Thomas, Yves Pommier, David S. Schrump, Markku Miettinen, Haobin Chen - Journal of Thoracic Oncology 2021 cited by 150

  14. Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents

    Authors: Gabriele Zoppoli, Marie Regairaz, Elisabetta Leo, William C. Reinhold, Sudhir Varma, Alberto Ballestrero, James H. Doroshow, Yves Pommier - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 375

  15. Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

    Authors: Junko Murai, Shar-yin N. Huang, Amèlie Renaud, Yiping Zhang, Jiuping Ji, Shunichi Takeda, Joel Morris, Beverly A. Teicher, James H. Doroshow, Yves Pommier - Molecular Cancer Therapeutics 2013 cited by 758

  16. Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

    Authors: Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli, Kelli M. Wilson, Yang Zhang, Erin Beck, Linda Sciuto, Samantha Nichols, Brian Elenbaas, Janusz Puc, Heike Dahmen, Astrid Zimmermann, Jillian Varonin, Christopher W. Schultz, Se Hyun Kim, Hirity Shimellis, Parth Desai, Carleen Klumpp‐Thomas, Lu Chen, Jameson Travers, Crystal McKnight, Sam Michael, Zina Itkin, Sunmin Lee, Akira Yuno, Min-Jung Lee, Christophe E. Redon, Jessica D. Kindrick, Cody J. Peer, Jun S. Wei, Mirit I. Aladjem, William D. Figg, Seth M. Steinberg, Jane B. Trepel, Frank T. Zenke, Yves Pommier, Javed Khan, Craig J. Thomas - Cancer Cell 2021 cited by 177

  17. BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality

    Authors: Junko Murai, Yves Pommier - Cancer Research 2023 cited by 127

  18. The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin

    Authors: Dragomir B. Krastev, Shudong Li, Yilun Sun, Andrew J. Wicks, Gwendoline Hoslett, Daniel Weekes, Luned Badder, Eleanor Knight, Rebecca Marlow, Mercedes Pardo, Lu Yu, Tanaji T. Talele, Jiří Bártek, Jyoti S. Choudhary, Yves Pommier, Stephen J. Pettitt, Andrew Tutt, Kristijan Ramadan, Christopher J. Lord - Nature Cell Biology 2022 cited by 162

  19. Genome Organization Drives Chromosome Fragility

    Authors: Andrés Canela, Yaakov Maman, Seolkyoung Jung, Nancy Wong, Elsa Callén, Amanda Day, Kyong-Rim Kieffer-Kwon, Aleksandra Pękowska, Hongliang Zhang, Suhas S.P. Rao, Su-Chen Huang, Peter J. McKinnon, Peter D. Aplan, Yves Pommier, Erez Lieberman Aiden, Rafael Casellas, André Nussenzweig - Cell 2017 cited by 423

  20. Targeting Topoisomerase I in the Era of Precision Medicine

    Authors: Anish Thomas, Yves Pommier - Clinical Cancer Research 2019 cited by 329

  21. SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures

    Authors: Camille Tlemsani, Lőrinc Sándor Pongor, Fathi Elloumi, Luc Girard, Kenneth E. Huffman, Nitin Roper, Sudhir Varma, Augustin Luna, Vinodh N. Rajapakse, Robin Sebastian, Kurt W. Kohn, Julia Krushkal, Mirit I. Aladjem, Beverly A. Teicher, Paul S. Meltzer, William C. Reinhold, John D. Minna, Anish Thomas, Yves Pommier - Cell Reports 2020 cited by 168

  22. SLFN11 Blocks Stressed Replication Forks Independently of ATR

    Authors: Junko Murai, Sai-Wen Tang, Elisabetta Leo, Simone A. Baechler, Christophe E. Redon, Hongliang Zhang, Muthana Al Abo, Vinodh N. Rajapakse, Eijiro Nakamura, Lisa M. Jenkins, Mirit I. Aladjem, Yves Pommier - Molecular Cell 2018 cited by 279

  23. Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents

    Authors: Ukhyun Jo, Ilya S. Senatorov, Astrid Zimmermann, Liton Kumar Saha, Yasuhisa Murai, Se Hyun Kim, Vinodh N. Rajapakse, Fathi Elloumi, Nobuyuki Takahashi, Christopher W. Schultz, Anish Thomas, Frank T. Zenke, Yves Pommier - Molecular Cancer Therapeutics 2021 cited by 111

  24. RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription

    Authors: Laura Baranello, Damian Wójtowicz, Kairong Cui, Ballachanda N. Devaiah, Hye-Jung Chung, Ka Yim Chan-Salis, Rajarshi Guha, Kelli M. Wilson, Xiaohu Zhang, Hongliang Zhang, Jason Piotrowski, Craig J. Thomas, Dinah S. Singer, B. Franklin Pugh, Yves Pommier, Teresa M. Przytycka, Fedor Kouzine, Brian A. Lewis, Keji Zhao, David Levens - Cell 2016 cited by 311